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2Abstract
The experience of maternal distress in pregnancy is often linked with poorer obstetric outcomes 
for women as well as adverse outcomes for offspring. Alterations in placental glucocorticoid 
signalling and subsequent increased fetal exposure to cortisol have been suggested to underlie 
this relationship. In the current study, 121 pregnant women completed the Perceived Stress 
Scale, State Trait Anxiety Inventory and Edinburgh Postnatal Depression Scale in the third 
trimester of pregnancy. Placental samples were collected after delivery. Maternal history of 
psychiatric illness and miscarriage were significant predictors of poorer mental health in 
pregnancy. Higher anxiety was associated with an increase in women delivering via elective 
Caesarean Section, and an increase in bottle-feeding. Birth temperature was mildly reduced 
among infants of women with high levels of depressive symptomology. Babies of mothers who 
scored high in all stress (cumulative distress) measures had reduced 5-minute Apgar scores. 
High cumulative distress reduced the expression of placental HSD11B2 mRNA and increased 
the expression of placental NR3C1 mRNA. These data support a role for prenatal distress as a 
risk factor for altered obstetric outcomes. The alterations in placental gene expression support 
a role for altered placental glucocorticoid signalling in the relationship between maternal 
prenatal distress and adverse outcomes. 
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31. Introduction
There is now an extensive body of evidence showing that the in utero experience is a critical 
determinant of fetal outcome (Langley-Evans, 2006).  One factor that has been extensively 
studied in this regard is the adverse effect of maternal prenatal distress on birth outcomes 
(Bussières et al., 2015). This is important, as understanding the relationship between prenatal 
distress and unfavourable births outcomes may allow for targeted maternal or fetal surveillance 
in high-risk pregnancies, or timely intervention to decrease the risk of an adverse outcome. The 
term ‘prenatal distress’ is often used to collectively refer to negative psychological wellbeing, 
and encompasses stress, anxiety and depression. The prevalence of prenatal distress is 
estimated to be 31%, 28% and 12% for stress, anxiety and depression respectively (McDonald 
et al., 2013).  Thus, a significant proportion of women experience clinically significant levels 
of maternal distress during pregnancy, highlighting the need to study its impact on birth 
outcomes.  
A number of epidemiological studies have shown that fetal exposure to maternal 
prenatal distress can alter fetal development and increase short and long term disease risk. 
Prenatal stress and anxiety increases the risk of preterm birth (PTB) and low birth weight 
(LBW) (Bussières et al., 2015; Ding et al., 2014; Khashan et al., 2009; Khashan et al., 2008). 
Prenatal depression has been found to increase the risk of operative deliveries (Hu et al., 2015), 
PTB and LBW (Grote et al., 2010). However, in a more recent meta-analysis, Accortt and 
colleagues reported significant variability in existing studies (Accortt et al., 2015), highlighting 
the need for further studies examining the association between prenatal depression and birth 
outcomes. 
While the clinical outcomes have been the subject of intensive investigation, the 
molecular and biological parallels of these changes in human population is not well known. 
4Given the well-known effect of stress on glucocorticoid signalling, one proposed hypothesis is 
that alterations in placental glucocorticoid signalling, leads to overexposure of the fetus to 
maternal cortisol (Cottrell et al., 2013). This has been proposed as a key biological mechanism 
underpinning the programming effect of prenatal distress on poor outcomes (Cottrell et al., 
2013). In particular, prenatal distress has been shown to alter the expression of three important 
genes in the placenta; 11-beta hydroxysteroid dehydrogenase type 2 (HSD11B2) (Jensen Pena 
et al., 2012; O'Donnell et al., 2012; Seth et al., 2015), the glucocorticoid receptor (NR3C1) 
(Palma-Gudiel et al., 2015) and FK506 binding protein (FKBP5) (Monk et al., 2016). 
Expression of these genes have been shown to correlate with infant birthweight (Green et al., 
2015; Mulligan et al., 2012) and growth restriction (Zhao et al., 2014), suggesting that an 
altered placental glucocorticoid signalling may play a role in determining newborn outcome.   
Further alterations in the epigenetic status and expression of HSD11B2 (Appleton et al., 2015), 
NR3C1 (Sheinkopf et al., 2016), and FKBP5 (Paquette et al., 2014) have been shown to 
predictive of neurobehavioral problems in infancy. 
The primary objective of this study was to evaluate the link between prenatal stress, 
depression and/or anxiety in late pregnancy on neonatal and obstetric outcomes in pregnant 
women receiving antenatal care at Cork University Hospital. The secondary goal was to 
examine whether prenatal stress, depression and/or anxiety in late pregnancy led to any changes 
in key genes involved in placental glucocorticoid signalling that have previously been linked 
to unfavourable birth outcomes and poorer neurodevelopment in infancy.
52. Materials and Methods
2.1 Participant recruitment
This study was carried out with full ethical approval from the Research Ethics Committee of 
Cork Teaching Hospital. Participants attending antenatal care at Cork University Maternity 
Hospital (CUMH), Cork, Ireland between July 2015 and September 2016 were invited to 
participate in this study.  The inclusion criteria were; 1. 18 years of age or older, 2. English 
speaking, 3. having a current singleton pregnancy and 4. plans to give birth in in the maternity 
hospital. The participants were recruited when they were greater than 28 weeks’ gestation to 
time of delivery. Participants were recruited in late pregnancy as this time corresponds to a 
period with a high prevalence of prenatal distress (Lee et al., 2007).  Written informed consent 
was obtained from all women who agreed to take part and participants were asked to complete 
a combination of questionnaires to assess maternal distress (Khashan et al., 2014) and donate 
a small biopsy of their placenta following delivery. Detailed clinical and demographic data 
were collected from the medical notes of patients once the entire cohort had given birth. This 
data included information on maternal age, body mass index (BMI), previous obstetric 
complications, previous psychiatric history, medical conditions, current obstetric 
complications, birthweight, gender, gestational age, Apgar score, birth temperature, head 
circumference, neonatal resuscitation (if any), admissions to the neonatal intensive care unit 
(NICU) and mode of feeding on discharge from the hospital. 
2.2 Questionnaires
This study used the 10-item Perceived Stress Scale (PSS). The PSS is a popular tool used to 
measure psychological stress and how individuals appraise stressful life events (Cohen et al., 
1983). Higher Scores on the PSS are indicative of a higher level of perceived stress. In this 
study, a score of greater than or equal to 20 was used as the cut-off for the ‘high stress’ group. 
6Maternal anxiety was measured using the 6-item version of State Trait Anxiety Inventory 
(STAI). The 6 item STAI is a frequently used brief psychological measure of anxiety and the 
6 item version which has been validated for use during pregnancy (Marteau and Bekker, 1992). 
As there are currently no recommended cut off scores for the STAI during pregnancy, women 
were deemed anxious if they scored in the top 25% of the cohort. Depressive symptoms were 
assessed using the Edinburgh Postnatal Depression Scale (EPDS). Consistent with previous 
studies, we used a score of 13 or greater to indicate a high probability of depression (Cohen et 
al., 1983; Rubertsson et al., 2011). These self-reported questionnaires were marked by a 4-
point Likert Scale. In this study, the Cronbach’s alpha of the PSS, STAI and EPDS were 0.867, 
0.838 and 0.894 respectively. 
2.3 Placental collection
Placental samples were collected within 3 hours of delivery. Placental weight was measured 
after the cord and membranes had been removed. 5 cross-sectional samples were randomly 
excised from each placenta to incorporate both the maternal and fetal sides. The samples were 
washed in dH2O and immediately stored at -80 °C until further analysis. 
2.4 RNA extraction, cDNA synthesis and PCR
RNA was extracted from placental samples using the Trizol method as per the manufacturer’s 
instructions. Briefly, placental sample was homogenised in 3 ml of Trizol reagent and left on 
ice for 10 min. Samples were centrifuged at 12,000g for 5 min at 4°C and 1 ml of the 
supernatant was transferred into a new tube. 200l of chloroform was added, mixed and left at 
room temperature for 3 min. The sample was centrifuged at 12,000g for 15 min at 4°C. The 
upper clear aqueous phase was removed and placed in a new 1.5ml tube, 500l of isopropanol 
7was added and left at room temperature for 10 min. The samples were centrifuged at 12,000g 
for 10 min at 4°C. The supernatant was removed and the pellet was washed in 1 ml of 70% 
ethanol. The samples were again centrifuged, the supernatant was removed and the pellet was 
left to air dry and re-suspended in 70l of RNase free H2O. RNA concentration and quality 
was assessed using the Nanodrop 8000.  500 ng of placental RNA was reversed transcribed 
using the high capacity cDNA reverse transcription kit (Applied Biosystems) using the 
following parameters 25 °C for 10 min; 37 °C for 120 min; 85 °C for 5 min; and held at 4 °C 
until storage at 80 °C. Real time PCR was performed for HSD11B2, FKBP5, NC3R1 under the 
following cycling parameters; 50 °C for 2 min; 95 °C for 10 min; 40 repetitions of 95 °C for 
15 s and annealing/elongating at 60 °C for 1 min. All samples were run in duplicate, cycle 
threshold values were recorded and analysis was performed using the 2−ΔΔcycle threshold 
method (Livak and Schmittgen, 2002). 
2.5 Data analysis
Data was collected and analysed on SPSS version 22 and Graphpad prism 5. Missing values 
were checked for and any questionnaire response with greater than 3 missing values were 
removed. Where medical records were unavailable, participants’ questionnaire scores were 
also removed from the cohort. Normality was tested for using the Kolmogorov-Smirnov tests 
prior to beginning inferential statistics. Birthweight, birthweight centiles and placental weight 
ratios were normally distributed and were analysed using an unpaired student t-tests or one-
way ANOVA with Tukeys post hoc. Placental weight, Apgar scores, birth temperature and 
head circumference displayed a non-normal distribution, therefore non parametric tests were 
used. For nominal data, binary logistic regression analysis with 95% confidence intervals was 
used. Multivariate data were evaluated with ordinal logistic regression analysis. Values of p < 
80.05 were consider statistically significant. All analyses were adjusted for maternal age, body 
mass index (BMI) and social class. 
In our analysis we grouped mode of delivery into 3 models. In model 1, mode of 
delivery was grouped as either spontaneous vaginal delivery (SVD) or operative. Model 2 
included vaginal delivery versus caesarean section (CS) delivery.  Model 3 grouped delivery 
as SVD, emergency CS (EMCS), elective CS (ELCS), vacuum (VD) or forceps delivery (FD). 
Additionally newborns were grouped into number of adverse birth outcomes based on six 
parameters; (a) admission to the NICU (b) newborn resuscitation received (c) delivered before 
37 weeks’ gestation (d) 5 minute Apgar score ≤ 7 (e) birth temperature < 36.5°C and (f) birth 
centile ≤ 10 or ≥ 90.
93. Results:
3.1 Descriptive statistics
159 pregnant women were initially recruited into the study and completed the questionnaires. 
Participants were removed from the study if they were less than 28 weeks’ gestation when they 
completed the questionnaires (13%), had incomplete survey information (3%) or if medical 
records were unavailable (7.5%) (Fig. 1). The final analysis included 121 participants. The 
mean age of the participants was 31.75 years (SD = 4.54, range 17 – 41). The average BMI 
was 26.33 (SD = 4.60, range 18.6 – 38.8). The mean gestational age at which the surveys were 
completed was 35.55 weeks’ (SD 3.541, range 28 -41). The majority of the women in this study 
where multigravida (67.8%) or primigravida (26.4%). 2.5% of participants had delivered 
greater than 5 infants and 3.3% had greater than 7 previous deliveries. 23.1% of this population 
had a history of having one or more miscarriages (n = 28). Only 2 participants (1.7%) had a 
history of ectopic pregnancies and therefore no further analysis was conducted in relation to 
ectopic pregnancy history. 21.5% of the study population had a history of psychiatric illness (n 
= 26). Depression was the most common psychiatric illness in this population (9.9%, n=12), 
followed by anxiety (7.4%, n=9), postnatal depression (5%, n=6) and bipolar disorder (0.8%, 
n=1) (Table 1 & 2). 
3.2 Perceived Stress Scale: 
The mean PSS score in the entire study cohort was 16.36 ± 0.59 (Supplementary Fig.1 & Table 
1). This number is comparable to other studies that have used the 10-item PSS to assess prenatal 
stress in the third trimester (Liou et al., 2013).   High levels of perceived psychological stress 
was determined by a PSS score of greater than or equal to 20 (33.1%, n = 40). Participants with 
a score of less than or equal to 19 were deemed ‘low stress’ (66.9%, n=81). Women with high 
levels of stress during pregnancy were 2 times more likely to have a history of psychiatric 
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illness (OR 2.519; 95% CI=1.036–6.125). This relationship remained significant after 
controlling for maternal age, BMI and social class (aOR 2.591; 95% CI=1.033 – 6.499). When 
grouped based on type of psychiatric illness, maternal stress was not associated with 
depression, anxiety or PND individually (Table 3). Prenatal stress had no effect neonatal 
outcome (Fig. 2), mode of delivery, gestational age at delivery or infant feeding (Table 3). 
Additionally scoring on the PSS was related to neonatal resuscitations, admission to the NICU, 
birth centiles (Supplementary Table 2) or number of neonatal adversities (Supplementary Table 
3).
3.3 State Trait Anxiety Inventory:
The mean score in the STAI was 6.17 ± 0.35 (Supplementary Fig.1 & Table 1). As there are 
currently no guidelines to indicate high anxiety in the perinatal period using the STAI, we 
defined highly anxious as the top quartile of scores in the cohort (27.3%, n=33). Previous 
depression, anxiety or PND alone was not associated with scoring in the STAI. However, when 
grouped by any psychiatric illness there was an association with scoring high in the STAI and 
having a history of psychiatric illness (OR 3.020; 95% CI=1.215–7.509). This relationship 
remained significant after including maternal age, BMI and social class into the model 
(aOR3.532; 95% CI=1.322-9.389) (Table 4). A history of miscarriage was associated with a 3 
fold increased risk of scoring high in STAI (aOR 3.807; 95% CI=1.384-10.473) (Table 4), 
indicating previous pregnancy loss as a contributing factor to anxiety during pregnancy. 
Maternal anxiety was not related to the neonatal outcomes measured (Fig. 3). Women who 
scored in the high anxiety group were more than twice as likely to have an operative delivery 
as oppose to SVD (OR 2.443; 95% CI = 1.077-5.545). When analysed in model 3 this rose to 
a 4 fold increased risk of delivery via ELCS (OR 4.154; 95% CI = 0.359-2.489). The 
relationship remained significant after including maternal age, BMI and social class into the 
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model (aOR 5.411; 95% CI = 0.509-2.868) (Table 4). Similarly, participants with high anxiety 
were 3 times more likely to deliver before 39 weeks’ gestation (aOR 3.235; 95% CI 1.182 – 
8.855) (Table 4). Women who scored high on the STAI were more likely to bottle feed their 
infant prior to discharge from the hospital (aOR 2.710; 95% CI = 0.086-1.908) (Table 4). 
3.4 Edinburgh Postnatal Depression Scale:
The mean EPDS was 9.07 ± 0.51 (Supplementary Fig.1 & Table 1). An EPDS score greater 
than or equal to 13 was used to mark participants as being ‘highly likely depressed’ (25.6%, 
n=31). Concordantly, participants who scored 12 or less were grouped in the ‘not likely 
depressed’ category (74.4%, n = 90).  Participants who scored in the ‘highly likely depressed’ 
group were greater than 3 time more likely to have had a history of psychiatric illness (aOR 
3.566; 95% CI=1.348-9.434). When stratified based on type of psychiatric illness (depression, 
stress or anxiety), women with a history of depression were 4 times more likely to be in the 
‘highly likely depressed’ group after adjusting for maternal age, BMI and social class (aOR 
4.451; 95% CI=1.198-16.538) (Table 5). Maternal history of miscarriage was associated with 
a three-fold increased risk of scoring high in the EPDS (aOR 3.878; 95% CI=1.420-10.590) 
(Table 5). Babies of women who were ranked in the ‘highly likely depressed’ group on the 
EPDS had a reduced temperature at birth (P < 0.05 *) (Fig. 4D). Maternal depressive 
symptomology did not affect mode of delivery, gestational age at delivery or infant feeding 
(Table 5). Additionally scoring on the EPDS was related to neonatal resuscitations, admission 
to the NICU, birth centiles (Supplementary Table 2) or number of neonatal adversities 
(Supplementary Table 3). 
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3.5 Cumulative group
As prenatal stress, anxiety and depression are highly correlated (Supplementary Fig. 2), a new 
exploratory group was created for participants who scored in the high category on all three 
questionnaires (14.9%, n= 18). Participants in this group were up to 3 times more likely to 
have a history of miscarriage (aOR = 3.903; 95% CI=1.224-12.446) (Table 6). The risk of 
having a history of psychiatric illness in this group rose to greater than 6 times (aOR = 6.229; 
95% CI = 1.947-19.926). Similar to participants who ranked high in the EPDS, participants in 
this category were more likely to have a history of depression (aOR = 4.504; 95% CI=1.073-
18.897) (Table 6). Infants born to women in the cumulative high stress group had a lower 5 
minute Apgar score than other infants. Further, unlike babies from the low group, babies born 
to mothers in this group did not have a significant increase in their Apgar score from 1 to 5 
minutes (Fig. 4E).  Maternal cumulative distress had no effect on mode of delivery, gestational 
age at delivery or infant feeding (Table 6). 
3.6 Placental gene expression:
To determine the relationship between prenatal distress and the expression of genes that play 
crucial roles in placental glucocorticoid signalling, we performed real time PCR on placental 
samples for three key genes; HSD11B2, FKBP1, NR3C1. Placentae were available for 16 of 
the high cumulative distress participants and 9 of the low scoring participants. Scoring in the 
high group was associated with a significant decrease in HSD11B2 (p = 0.0296) and an increase 
in NR3C1 (p=0.048) mRNA in the placenta (Fig. 6). Additionally placental NR3C1 was 
negatively correlated with placental weight (r2 = 0.159; p=0.025) and birthweight centiles (r2 
= 0.412; p=0.036) (Supplementary Table 5). There was no effect of prenatal cumulative distress 
on the expression of FKBP5 (p=0.101) (Fig 6).  Placental FKBP5 expression positively 
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correlated with maternal BMI (r2 = 0.185; p=0.025) (Supplementary Table 6). Placental gene 
expression was not related to infant sex or obstetric outcomes (Supplementary Fig. 3) 
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4. Discussion:
The present study adds to the existing literature highlighting a negative role for prenatal distress 
in mediating adverse pregnancy and birth outcomes. Prenatal stress is commonly reported 
during pregnancy and varies in its definition. Psychological wellbeing encompasses a broad 
area of health that expands beyond diagnosable mental health disorders such as depression, 
anxiety and posttraumatic stress disorder.  There are a wide range of screening tools used to 
identify women who may be at risk of stress, anxiety and depression that are commonly used 
to measure psychological status in pregnancy. The extensive tools available means prenatal 
stress is commonly defined and assessed in multiple ways, which has led to significant 
inconsistencies between studies. To characterise psychological distress in this study, we used 
the PSS, STAI and EPDS. A large meta-analysis demonstrated these questionnaires to have 
excellent reliability and to currently be the best available tools to measure stress, anxiety and 
depressive symptomology during pregnancy (Nast et al., 2013). 
The current study does not support a strong association between maternal prenatal 
distress and neonatal outcomes. Although we identified a significant reduction in birth 
temperature among neonates from women with high depressive symptoms, and reduced new-
born temperature is related to increased infant mortality (Soll, 2008), we recommend this result 
be interpreted with caution as infants of mothers who report depression had an average 
temperature of 36.43 °C, and infants are only considered clinically hypothermic when 
temperature drops below 36°C. We also found a reduction in the five minute Apgar score 
among babies from the high cumulative stress group. Further these babies did not display an 
increase in Apgar scores from 1 to 5 minutes. A low 5-minute Apgar score is associated with 
infant mortality (Thorngren-Jerneck and Herbst, 2001) and is predictive of poor neurological 
function later in life (Lie et al., 2010) (Moster et al., 2001; Seidman et al., 1991). 
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We found that prenatal anxiety was associated with an increased risk of women 
delivering via elective Caesarean Section and delivering before 39 weeks’ gestation. The 
reduced gestation observed among these women is likely a reflection of the increased rates of 
elective CS in this highly anxious group, which are often scheduled for 39 weeks’ gestation 
(Laye and Dellinger, 2006).  In line with previous studies (Fairlie et al., 2009), we showed that 
women with high levels of anxiety in late pregnancy were more likely to bottle feed their infants 
prior to hospital discharge. This highlights a central role for anxiety in late pregnancy to 
mediate adverse obstetric outcomes, and may have implications for mode of feeding in the 
post-partum period. 
Fetal over-exposure to maternal cortisol as a mediator of adverse fetal outcomes is well 
described in the literature (Reynolds, 2013). In the placenta, the fetus is protected from high 
levels of maternal cortisol by the actions of the enzyme HSD11B2. This enzyme breaks down 
cortisol into its inactive product cortisone and in doing so prevents fetal overexposure to 
maternal cortisol. Scientific enquires are now focusing on this enzyme to be a mediator of 
prenatal stress as depression in the perinatal period have been shown to reduce the expression 
of this enzyme in the placenta (Togher et al., 2014). Here we demonstrate a significant 
reduction in the expression of placental HSD11B2 mRNA in women who were in the high 
cumulative stress group. Additionally we find this group to have elevated levels of the NR3C1 
receptor mRNA in the placenta and show a negative correlation between NR3C1 mRNA 
expression and birthweight. The association between these placental genes with infant 
neurodevelopment (Appleton et al., 2015), suggests dysregulation of these genes may lie at the 
core of the relationship between prenatal distress and adverse infant outcomes and highlights 
the potential to use these genes as potential biomarkers for altered neurodevelopment in 
infancy. This also suggests that molecular signatures of prenatal stress exposure may be present 
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in the placenta at birth which suggests that the placenta may be an accessible molecular 
barometer of the degree of stress exposure during pregnancy.  
We identified a maternal history of psychiatric illness or miscarriage as significant 
predictors of poorer mental health in pregnancy. This is in line with previous studies where 
women with a history of early pregnancy loss have elevated levels of stress, anxiety and 
depression in subsequent pregnancies (McCarthy et al., 2015; Woods-Giscombé et al., 2010). 
Identifying these women and offering support measures to reduce the risk of mood disturbance 
in their current pregnancy may be beneficial in reducing neonatal and obstetric complications. 
Of interest prenatal yoga has been shown to enhance positive mood, reduce depressive and 
anxiety symptoms (Davis et al., 2015), and decrease salivary cortisol and alpha amylase levels 
(a marker of HPA activity) (Kusaka et al., 2016) in pregnancy. Additionally, a preliminary 
RCT showed significant improvement in anxiety and depressive symptoms in women receiving 
an antenatal mindfulness intervention (Woolhouse et al., 2014). Furthermore the ‘Centering 
Pregnancy’ trial which promotes group prenatal care has been shown to reduce rates of preterm 
birth and enhance breastfeeding initiation and is widely implemented across the United States 
(Ickovics et al., 2007). Examining the effectiveness of such strategies in a country specific 
manner will be crucial in progressing clinical practise and promoting interventions to manage 
maternal distress in pregnancy to ultimately improve maternal and birth outcomes in this high 
risk population.  
Study limitations
The current study has several limitations. First the relatively limited sample size in this cohort 
may explain why we do not find an effect with prenatal distress and birth and placental weight. 
Additionally enrolling women after 28 weeks’ gestation precludes our ability to measure any 
association with extremely PTB. Furthermore the earliest age at delivery in this cohort was 37 
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weeks’ gestation which prevented us from investigating an association with pre-term delivery, 
which has a background incidence in our population of 4%. The limited ethnicity of our cohort 
did not allow us to examine any ethnic differences, which is an important factor when 
considering prenatal distress (Borders et al., 2015).  Moreover, measuring maternal distress in 
late pregnancy only underscores the importance of other vulnerable periods during gestation. 
Finally, we were unable to assess or control for maternal antidepressant use or lifestyle factors 
such as exercise, diet, smoking or alcohol intake which may mediate the relationship between 
prenatal distress and adverse outcomes (Shapiro et al., 2013)
Conclusions
Despite these limitations the current study is important as it identifies prenatal anxiety in late 
pregnancy as a significant factor leading to increased opting for Caesarean Section delivery 
and increased bottle feeding of infants. Addtionally the changes in placental HSD11B2 and 
NR3C1 mRNA expression further supports the findings that prenatal distress can change the 
expression of genes playing a crucial role in placental glucocorticoid signalling in human 
populations. It also support the potential involvement of this mechanism in the programming 
effects of prenatal distress.   Further studies conducted longitudinally throughout pregnancy 
and including both psychological and physiological measures of distress in larger and more 
ethnically diverse populations will help to clarify vulnerable individuals specifically at risk. 
Translating these results into prenatal clinics and establishing interventions to manage distress 
in pregnancy will be crucial in reducing morbidities in pregnancy and neonates. 
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Figures
Figure 1: Flowchart of participants
Figure 1: 159 questionnaires were completed with 21 (13.2%) removed from the dataset for 
being less than 28 weeks gestation and a further 5 (3.1%) removed for incomplete filling of the 
questionnaire. Medical records were unavailable for 12 (7.5%) of the participants. Placental 
samples were collected,  frozen and biobanked for 100  of the remaining participants (82.6%). 
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Table 1: Descriptive statistics of categorical variables
Demographics N (%)
Age (years)
≤ 18 
19 – 24 
25 – 29 
30 – 35 
≥ 35 
*Missing
1 (0.8%)
8 (6.7%)
26 (21.8%)
48 (40.3%)
36 (30.3%)
2 (1.7%)
BMI (kg/m2)
Underweight (< 18.50)
Normal (18.5 – 24.99)
Overweight (25 – 29.9)
Obese (> 30.0)
*Missing
0
50 (41.7%)
44 (36.4%)
26 (21.5%)
1 (0.8%)
Social class
1. Professional workers
2. Managerial and technical
3. Non-manual
4. Skilled manual
5. Semi-skilled
6. Unskilled
7. Unemployed
8. Missing
14 (11.6%)
37 (30.6%)
8 (6.6%)
28 (23.1%)
9 (7.4%)
8 (6.6%)
6 (5%)
11 (9.1%)
21
Medical History
History of miscarriage
Yes
No
History of ectopic pregnancy
Yes
No
28 (23.1%)
93 (76.9%)
2 (1.7%)
119 (98.3%)
Psychiatric history
History of  any psychiatric illness
Yes
No
History of depression
Yes
No
History of anxiety
Yes
No
History of postnatal depression
Yes
No
26 (21.5%)
95 (78.5%)
12 (9.9%)
109 (90.1%)
9 (7.4%)
112 (92.6%)
6 (5%)
115 (95%)
Onset of delivery
Spontaneous
Induction
*missing
51 (50.5%)
50 (49.5%)
20 (16.5%)
Rupture of membranes
22
SROM
PROM
AROM
35 (34%)
3 (2.9%)
65 (63.1%)
Mode of delivery
Spontaneous vaginal delivery 
(SVD)
Forceps delivery (FD)
Vacuum delivery (KVD)
Emergency Casearan section 
(EMCS)
Elective Casearan section (ELCS)
67 (55.8%)
4 (3.3%)
19 (15.8%)
10 (8.3%)
20 (16.7%)
Resuscitation at birth
Yes
No
17 (14.4%)
101 (85.6%)
Admission to the Neonatal Unit
Yes
No
5 (4.2%)
115 (95.8%)
Mode of Feeding on discharge
Exclusive breast fed
Mixed feeding
Bottle fed
56 (46.3%)
7 (5.8%) 
58 (47.9%)
Table 1: Descriptive statistics of categorical variables
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Table 2: Descriptive statistics of continuous variables
Measure Mean (N) SEM SD Range
Maternal age 31.75 0.41 4.54 17 - 41
Maternal BMI 26.33 0.42 4.60 19 - 40
Birthweight 3654.67 40.66 445.49 2690 - 4800
Placental weight 558.33 10.84 106.29 300 - 900
Placental weight ratio 0.157 0.006 0.06 0.09 – 0.70
Birth Temperature 36.80 0.09 1.01 27 - 39
1 minute Apgar Score 8.54 0.10 1.19 3 - 10
5 minute Apgar Score 9.53 0.06 0.73 6 - 10
Gestational Age at delivery 39.58 0.09 1.04 37 - 41
Birthweight Centiles 47.58 2.46 26.87 1 - 98
Table 2: Descriptive statistics of continuous variables
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Figure 2: Prenatal stress and neonatal outcomes
Figure 2: Graphical representation of birthweight (A), placental weight (B), placental weight 
ratio (C), birth temperature (D) and Apgar score (E) in neonates whose mothers were ranked 
in the high and low stress category. Unpaired students t-test between low and high on birth 
weight (A) and placental weight ratio (C) show no significant difference between groups P > 
0.05. Mann Whitney test between low and high on placental weight (B) and birth temperature 
(D) show no significant difference between groups P > 0.05. Mann Whitney test show 
increased Apgar score from 1 to 5 minute (E) in low and high stress group (P < 0.0001 ***). 
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Table 3: Prenatal stress, maternal history and obstetric outcomes
Perceived Stress Scale
OR (CI; p-value) aOR (CI; p-value)
Psychiatric history
Psychiatric Illness 2.519 (1.036 – 6.125 ; 0.042) * 2.591 (1.033 – 6.499 ; 0.042) *
Depression 2.203 (0.663 – 7.338 ; 0.197) 2.648 (0.747 – 9.382 ; 0.131)
Anxiety 2.082 (0.696 – 10.867 – 0.149) 2.592 (0.622 – 10.796 ; 0.191)
Postnatal Depression 1.013 (0.178 – 5.780 ; 0.988) 0.837 (0.135 – 5.206 ; 0.849)
Miscarriage history
Miscarriage 1.741 (0.730 – 4.155 ; 0.211) 2.278 (0.878 – 5.911 ; 0.091)
Mode of delivery
SVD ref refModel 1
Operative 1.023 (0.478 – 2.190 ; 0.954) 1.014 (0.466 – 2.204 ; 0.972)
Vaginal ref refModel 2
CS 1.017 (0.423 – 2.441 ; 0.97) 1.178 (0.467 – 2.970 ; 0.729)
SVD ref ref
EMCS 0.511 (-2.302 – 0.961 ; 0.420) 0.503 (-2.345 – 0.969 ; 0.416)
ELCS 1.364 (-0.720 – 1.340 ; 0.555) 1.706 (-0.556 – 1.625 ; 0.337)
KVD 1.193 (-0.886 – 1.239 ; 0.745) 1.046 (-1.043 – 1.133 ; 0.935)
Model 3
FD 0.682 (-2.703 – 1.937 ; 0.746) 0.492 (-3.062 – 1.645 ; 0.555)
Gestational Age at delivery
< 39 weeks gestation 0.673 (0.284 – 2.252 ; 0.673) 0.758 (0.266 – 2.157 ; 0.603)
Mode of Feeding
Breastfed ref ref
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Bottle-fed 1.111 (-0.674-0.885; 0.791) 1.059 (-0.737 – 0.852 ; 0.887)
Mixed 0.844 (-1.902-1.564; 0.848) 1.094 (-1.710 – 1.890 ; 0.922)
Table 3: Odds ratios assessing the relationship between prenatal stress, history of psychiatric 
illness, history of miscarriage, mode of delivery, gestational age at delivery and mode of 
feeding.  Binary logistic regression analysis revealed participants with a history of psychiatric 
illness were more likely to score high on the PSS (P < 0.05 *). Adjusted for maternal age, BMI 
and social class.
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Figure 3: Prenatal anxiety and neonatal outcomes
Figure 3: Graphical representation of birthweight (A), placental weight (B), placental weight 
ratio (C), birth temperature (D) and Apgar score (E) in neonates whose mothers were ranked 
in the high and low anxiety category. Unpaired students t-test between low and high on birth 
weight (A) and placental weight ratio (C) show no significant difference between groups P > 
0.05. Mann Whitney test between low and high on placental weight (B) and and birth 
temperature (D) show no significant difference between groups P > 0.05. Mann Whitney test 
show increased Apgar score from 1 to 5 minute in low and high anxiety group (P < 0.0001 
***). 
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Table 4: Prenatal anxiety, maternal history and obstetric outcomes
State Trait Anxiety Inventory
OR (CI; p-value) aOR (CI; p-value)
Psychiatric history
Psychiatric Illness 3.020 (1.215 – 7.509 ; 0.017) * 3.532 (1.322 – 9.389 ; 0.012) *
Depression 2.066 (0.607 – 7.037 ; 0.246) 2.579 (0.699 – 9.515 ; 0.155)
Anxiety 1.367 (0.321 – 5.812 ; 0.672) 1.322 (0.275 – 6.358 ; 0.727)
Postnatal Depression 2.833 (0.542 – 14.806 ; 0.217) 2.509 (0.432 – 14.583 ; 0.306)
Miscarriage history
Miscarriage 3.163 (1.296 – 7.721 ; 0.011) * 3.807 (1.384 – 10.473 ; 0.010) *
Mode of delivery
SVD ref refModel 1
Operative 2.443 (1.077 – 5.545 ; 0.033) * 2.264 (0.977 – 5.246 ; 0.057)
Vaginal ref refModel 2
CS 2.222 (0.923 – 5.348 ; 0.075) 2.306 (0.895 – 5.937 ; 0.083)
SVD ref ref
EMCS 1.038 (-1.626 – 1.701 ; 0.965) 0.817 (-1.917 – 1.513 ; 0.817)
ELCS 4.154 (0.359 – 2.489 ; 0.009) ** 5.411 (0.509 – 2.868 ; 0.005) **
KVD 2.423 (-0.227 – 1.997 ; 0.119) 2.235 (-0.345 – 1.954 ; 0.170)
Model 3
FD 1.385 (-2.017 – 2.668 ; 0.785) 1.013 (-2.424 – 2.451 ; 0.992)
Gestational Age at delivery
< 39 weeks gestation 3.182 (1.196 – 8.467 ; 0.020) * 3.235 (1.182 – 8.855 ; 0.022) *
Mode of Feeding
Breastfed ref ref
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Bottle-fed 2.964 (0.195 –1.978; 0.017)* 2.710 (0.086 – 1.908 ; 0.032) *
Mixed 3.917 
(-0.293 – 3.023; 0.107)
5.189 (-0.148 – 3.441 ; 0.072)
Table 4: Odds ratios assessing the relationship between prenatal anxiety, history of psychiatric 
illness, history of miscarriage, mode of delivery, gestational age at delivery and mode of 
feeding.  Binary logistic regression analysis revealed participants with a history of psychiatric 
illness or specifically depression and miscarriage were more likely to score high on the STAI 
(P < 0.05 *). High anxiety was associated with an increased risk of delivery by ELCS (P < 0.01 
**). Prenatal anxiety related to increased risk of delivery before 39 weeks gestation (P < 0.05 
*). Women in the high anxiety group were more likely to be bottle feeding on hospital discharge 
(P < 0.05 *).  Adjusted for maternal age, BMI and social class.
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Figure 4: Prenatal depressive symptoms and neonatal outcomes
Figure 4: Graphical representation of birthweight (A), placental weight (B), placental weight 
ratio (C), birth temperature (D) and Apgar score (E) in neonates whose mothers were ranked 
in the high and low depressive category. Unpaired students t-test between low and high on birth 
weight (A) and placental weight ratio (C) show no significant difference between groups P > 
0.05. Mann Whitney test between low and high on placental weight (B) show no significant 
difference between groups P > 0.05. Mann Whitney test show decrease birth temperature (E) 
among the high depressive symptoms group (P < 0.05 *). Mann Whitney test show increased 
Apgar score from 1 to 5 minute in low and high depressive symptom group (P < 0.0001 ***). 
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Table 5: Prenatal depressive symptoms, maternal history and obstetric outcomes
Edinburgh Postnatal Depression Scale
OR (CI; p-value) aOR (CI; p-value)
Psychiatric history
Psychiatric Illness 3.429 (1.366 – 8.607 ; 0.009) ** 3.566 (1.348 – 9.434 ; 0.010) *
Depression 3.360 (0.995 – 11.341 ; 0.051) 4.451 (1.198 – 16.539 ; 0.026) *
Anxiety 2.519 (0.631 – 10.053 ; 0.191) 2.042 (0.475 – 8.776 ; 0.337)
Postnatal Depression 1.483 (0.258 – 8.522 ; 0.659) 1.111 (0.149 – 8.312 ; 0.918)
Miscarriage history
Miscarriage 3.611 (1.463 – 8.913 ; 0.005) ** 3.878 (1.420 – 10.590 ; 0.008) 
**
Mode of delivery
SVD ref refModel 1
Operative 1.739 (0.764 – 3.960 ; 0.187) 1.751 (0.743 – 4.128 ; 0.200)
Vaginal ref refModel 2
CS 1.344 (0.538 – 3.361 ; 0.527) 1.618 (0.592 – 4.419 ; 0.348)
SVD ref ref
EMCS 0.946 (-1.713 – 1.603 ; 0.948) 0.950 (-1.755 – 1.652 ; 0.953)
ELCS 2.038 (-0.379 – 1.804 ; 0.201) 2.456 (-0.275 – 2.072 ; 0.133)
KVD 1.747 (-0.574 – 1.691 ; 0.334) 1.521 (-0.777 – 1.617 ; 0.492)
Model 3
FD 3.786 (-0.715 – 3.378 ; 0.202) 3.485 (-0.869 – 3.366 ; 0.248)
Gestational Age at delivery
< 39 weeks gestation 2.154 (0.792 – 5.855 ; 0.133) 2.391 (0.841 – 6.796 ; 0.102)
Mode of Feeding
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Breastfed ref ref
Bottle-fed 1.520 
(-0.433-1.272; 0.336)
1.301 (-1.621 – 2.147 ; 0.784)
Mixed 1.467 
(-1.377-2.143; 0.670)
1.337 (-0.594 – 1.175 ; 0.520)
Table 5: Odds ratios assessing the relationship between prenatal depressive symptoms, history 
of psychiatric illness, history of miscarriage, mode of delivery, gestational age at delivery and 
mode of feeding.  Binary logistic regression analysis revealed participants with a history of 
psychiatric illness or specifically depression and miscarriage were more likely to score high on 
the EPDS (P < 0.05 *, P < 0.01 **). Adjusted for maternal age, BMI and social class.
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Figure 5: Prenatal cumulative distress and neonatal outcomes
Figure 5: Graphical representation of birthweight (A), placental weight (B), placental weight 
ratio (C), birth temperature (D) and Apgar score (D) in neonates whose mothers were ranked 
in the high and low cumulative distress category. Unpaired students t-test between low and 
high on birth weight (A) and placental weight ratio (C) show no significant difference between 
groups P > 0.05. Mann Whitney test between low and high on placental weight (B) and birth 
temperature (D) show no significant difference between groups P > 0.05. Mann Whitney test 
show increased Apgar score from 1 to 5 minute in low cumulative distress group (P < 0.0001 
***) but not in high group (P > 0.05). Significant reduction in 5 minute Apgar score among 
high cumulative distress group (F; Mann Whitney test; P < 0.05 *). 
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Table 6: Prenatal cumulative distress, maternal history and obstetric outcomes
Cumulative distress 
OR (CI; p-value) aOR (CI; p-value)
Psychiatric history
Psychiatric Illness 5.059 (1.752 – 14.606 ; 0.003) ** 6.229 (1.947 – 19.926 ; 0.002) **
Depression 3.393 (0.902 – 12.763 ; 0.071) 4.504 (1.073 – 18.897 ; 0.040) *
Anxiety 3.233 (0.730 – 14.329 ; 0.122) 3.411 (0.649 – 17.916 ; 0.147)
Postnatal Depression 3.094 (0.523 – 18.302 ; 0.213) 3.136 (0.427 – 23.036 ; 0.261)
Miscarriage history
Miscarriage 3.320 (1.162 – 9.488 ; 0.025) * 3.903 (1.224 – 12.446 ; 0.021) *
Mode of delivery
SVD ref refModel 1
Operative 2.193 (0.786 – 6.113 ; 0.133) 1.982 (0.684 – 5.739 ; 0.207)
Vaginal ref refModel 2
CS 1.646 (0.558 – 4.852 ; 0.366) 1.758 (0.545 – 5.672 ; 0.345)
SVD ref ref
EMCS 0.952 (-2.258 – 2.161 ; 0.965) 0.704 (-2.647 – 1.945 ; 0.765)
ELCS 2.857 (-0.230 – 2.329 ; 0.108) 4.375 (0.005 – 2.947 ; 0.049) *
KVD 2.286 (-0.526 – 2.179 ; 0.231) 2.307 (-0.596 – 2.267 ; 0.252)
Model 3
FD 2.857 (-1.345 – 3.445 ; 0.390) 2.121 (-1.843 – 3.346 ; 0.570)
Gestational Age at delivery
< 39 weeks gestation 1.557 (0.452 – 5.355 ; 0.483) 1.548 (0.431 – 5.558 ; 0.503)
Mode of Feeding
Breastfed ref ref
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Bottle-fed 1.638 (-0.535 – 1.522 ; 0.347) 1.409 (-0.730 – 1.415 ; 0.531)
Mixed - -
Table 6: Odds ratios assessing the relationship between prenatal cumulative distress, history of 
psychiatric illness, history of miscarriage, mode of delivery, gestational age at delivery and 
mode of feeding.  Binary logistic regression analysis revealed participants with a history of 
psychiatric illness or specifically depression and miscarriage were more likely to be in high 
cumulative distress group (P < 0.05 *, P < 0.01 **). Prenatal cumulative distress was associated 
with increased delivery by ELCS (Ordinal regression; P < 0.05 *). Adjusted for maternal age, 
BMI and social class.
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Figure 6: Placental gene expression
Figure 6: Real time PCR showing (A) HSD11B2, (B) NR3C1 and (C) FKBP5 expression in 
the term human placenta between participants in the low and high cumulative stress group 
using the 2-delta-Ct method (Low n=9, High n=15; Unpaired Student’s t-test P < 0.05 *).
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Supplementary Information
Supplementary figure 1: Participants groupings based on Questionnaire Scorings
Supplementary figure 1: Graphical representation of perceived stress scale (A), State Trait 
Anxiety Inventory (B) and Edinburgh Postnatal Depression Scale (C) scores between women 
ranked in the low and high categories. Unpaired student t-test show a significant difference 
between groups P < 0.001 ***, N=121. 
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Supplementary table 1: Global sample means of measured variables
Measure Population Low High
Mean ± SD (N) Mean ± SD (N) Mean ± SD (N)
Perceived Stress Scale 15.88 ± 6.5 (121) 12.75 ± 4.5 (81) 23.65 ± 2.4 (40)
State Trait Anxiety Inventory 6.17 ± 3.8 (121) 4.20 ± 2.1 (87) 11.21 ± 2.0 (34)
Edinburgh Postnatal Depression Scale 9.07 ± 5.6 (121) 6.52 ± 3.7 (90) 16.48 ± 2.9 (31)
Supplementary table 1: Global sample means of measured variables expressed as mean ± SD. 
High stress (PSS ≥ 20), low stress (PSS ≤ 19). High anxiety (STAI ≥ 9), low anxiety (STAI ≤ 
8). High probability of depression (EPDS ≥ 13), low probability of depression (EPDS ≤ 12).  
39
Supplementary table 2: Prenatal stress, anxiety and depression and other neonatal outcomes
Perceived Stress Scale
OR (CI ; p-value) aOR (CI ; p-value)
Birth centiles 0.429 (0.115 – 1.606 ; 0.209) 0.395 (0.104 – 1.501 ; 0.173)
Neonatal Resuscitation 0.404 (0.109 – 1.501 ; 0.176) 0.460 (0.122 – 1.743 ; 0.253)
NICU Admission 1.405 (0.225 – 8.774 ; 0.716) 1.572 (0.240 – 10.312 ; 0.637)
Stat Trait Anxiety Inventory
OR (CI ; p-value) aOR (CI ; p-value)
Birth centiles 1.279 (0.407 – 4.019 ; 0.673) 1.272 (0.396 – 4.080 ; 0.686)
Neonatal Resuscitation 1.142 (0.368 – 3.544 ; 0.818) 1.206 (0.375 – 3.873 ; 0.753)
NICU Admission 4.448 (0.708 – 27.954 ; 0.111) 1.109 (0.930 – 1.323 ; 0.250)
Edinburgh Postnatal Depression Scale
OR (CI ; p-value) aOR (CI ; p-value)
Birth centiles 0.650 (0.172 – 2.456 ; 0.525) 0.602 (0.152 – 2.382 ; 0.469)
Neonatal Resuscitation 0.618 (0.164 – 2.324 ; 0.476) 0.654 (0.165 – 2.593 ; 0.546)
NICU Admission 2.071 (0.329 – 13.032 ; 0.438) 1.857 (0.277 – 12.460 ; 0.524)
Cumulative
OR (CI ; p-value) aOR (CI ; p-value)
Birth centiles 0.363 (0.045 – 2.945 ; 0.342) 0.334 (0.039 – 2.855 ; 0.316)
Neonatal Resuscitation 0.764 (0.158 – 3.689 ; 0.738) 0.795 (0.158 – 4.003 ; 0.781)
NICU Admission 4.444 (0.685 – 28.828 ; 0.118) 1.007 (0.878 – 1.155 ; 0.919)
Supplementary table 2: Relationship between scoring in the PSS, STAI, and/or EPDS with 
infants in the lower 10th birth centile, neonatal resuscitations and NICU Admissions. Binary 
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logistic regression shows no significant difference between groups P>0.05. Adjusted for 
maternal age, BMI and social class.
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Supplementary figure 2: Intercorrelations of questionnaire scores
 Supplementary figure 2: Correlation matrices showing relationship between PSS, STAI and 
EPDS scores. Pearson correlation shows each questionnaire is significantly correlated. PSS and 
STAI (r = 0.521; P < 0.001 ***), PSS and EPDS (r = 0.724; P < 0.001 ***) and STAI and 
EPDS (r = 0.678; P > 0.001 ***). RStudio.
Supplementary table 3: Prenatal distress with number of newborn adversities
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Supplementary table 3: Odds ratios assessing the relationship between prenatal distress and 
number of newborn adversities. Newborns were grouped into number of adverse birth 
outcomes based on six parameters (a) Admission to the NICU (b) Newborn Resuscitation 
received (c) Delivered before 37 weeks gestation (d) 5 minute Apgar score ≤ 7 (e) Birth 
Perceived Stress Scale
OR (CI ; p-value) aOR (CI ; p-value)
1 adverse outcome 0.669 (-1.245 – 0.442; 0.351) 0.648 (-1.302 - 0.435; 0.328)
2 adverse outcomes 0.341 (-3.276 – 1.122; 0.337) 0.335 (-3.310 – 1.124; 0.334)
3 adverse outcomes 0.852 (-2.607 – 2.287; 0.898) 0.878 (-2.628 – 2.468; 0.474)
Stat Trait Anxiety Inventory
OR (CI ; p-value) aOR (CI ; p-value)
1 adverse outcome 0.914 (-0.974 – 0.794; 0.842) 0.860 (-1.076 – 0.773; 0.748)
2 adverse outcomes 1.325 (-1.492 – 2.055; 0.756) 1.440 (-1.445 – 2.174; 0.693)
3 adverse outcomes 1.325 (-2.174 – 2.736; 0.822) 0.809 (-2.769 – 2.346; 0.871)
Edinburgh Postnatal Depression Scale
OR (CI ; p-value) aOR (CI ; p-value)
1 adverse outcome 0.914 (-0.974 – 0.794; 0.842) 0.914 (-1.019 – 0.839; 0.849)
2 adverse outcomes -- --
3 adverse outcomes 1.325 (-2.174 – 2.736; 0.822) 1.090 (-2.517 – 2.690; 0.948)
Cumulative
OR (CI ; p-value) aOR (CI ; p-value)
1 adverse outcome 1.025 (-1.056 – 1.105; 0.965) 0.986 (-1.148 – 1.120; 0.981)
2 adverse outcomes -- --
3 adverse outcomes 2.818 (-1.449 – 3.521; 0.414) 1.610 (-2.143 – 3.094; 0.722)
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Temperature < 36.5°C and (f) Birth Centile ≤ 10 or ≥ 90. Ordinal logistic regression analysis 
revealed no significant effect (P > 0.05). Adjusted for maternal age, BMI and social class.
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Supplementary table 4: Linear regression analysis of placental HSD11B2 mRNA expression 
with maternal distress, demographics and neonatal outcomes
HSD11B2 R2 β-
coefficient
95% CI p-value
Birthweight 0.019 0.137 -0.783 – 1.547 0.505
Placental weight 0.037 0.119 -0.144 – 0.382 0.360
PWR 0.030 0.173 0.00 – 0.00 0.408
Birthweight centiles 0.012 0.109 -0.068 – 0.116 0.597
1 min Apgar 0.012 0.109 -0.002 – 0.003 0.597
5 min Apgar 0.011 0.103 -0.001 – 0.002 0.617
Birth Temperature 0.003 0.054 -0.001 – 0.001 0.794
Gravidity 0.000 -0.009 -0.009 – 0.009 0.964
Maternal Age 0.004 -0.064 -0.647 – 0.472 0.472
Maternal BMI 0.062 -0.248 -0.001 – 0.000 0.212
Social Class 0.009 -0.095 -0.954 – 0.594 0.636
PSS 0.137 -0.370 -0.051 – 0.001 0.058
STAI 0.070 -0.265 -0.025 – 0.005 0.181
EPDS 0.068 -0.260 -0.038 – 0.008 0.190
Supplementary table 4: Placental HSD11B2 expression and continuous variables. Linear 
regression analysis. P > 0.05.  
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Supplementary table 5: Linear regression analysis of placental NR3C1 mRNA expression with 
maternal distress, demographics and neonatal outcomes
NR3C1 R2 β-
coefficient
95% CI p-value
Birthweight 0.083 -0.288 -1961 – 325.796 0.153
Placental weight 0.159 -0.398 -790.258 - -2.667 0.049
PWR 0.086 -0.293 -0.867 – 0.146 0.155
Birthweight centiles 0.170 -0.412 -180 - -6.380 0.036
1 min Apgar 0.004 -0.064 -2.870 – 2.111 0.756
5 min Apgar 0.00 0.010 -1.714 – 1.794 0.962
Birth Temperature 0.038 -0.195 -1.267 – 0.455 0.340
Gravidity 0.003 -0.054 -9.854 – 7.583 0.791
Maternal Age 000 0.015 -547.008 – 588.035 0.941
Maternal BMI 0.023 0.151 -0.292 – 0.635 0.453
Social Class 0.005 0.074 -644.397 – 955.528 0.715
PSS 0.075 0.273 -8.437 – 45.959 0.168
STAI 0.003 0.052 -13.496 – 17.405 0.797
EPDS 0.007 0.084 -18.893 – 28.563 0.678
Supplementary table 5: Placental NR3C1 expression and continuous variables. Linear 
regression analysis. Placental weight and birthweight centiles associated with NR3C1 levels. 
P < 0.05 *. 
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Supplementary table 6: Linear regression analysis of placental FKBP51 mRNA expression 
with maternal distress, demographics and neonatal outcomes
FKBP51 R2 β-
coefficient
95% CI p-value
Birthweight 0.033 -0.183 -2955.102 – 
1147.112
0.372
Placental weight 0.109 -0.330 -1010.482 – 106.235 0.107
PWR 0.020 -0.140 -0.959 – 0.487 0.506
Birthweight centiles 0.150 -0.387 -308.452 – 0.616 0.051
1 min Apgar 0.011 0.107 -3.244 – 5.473 0.603
5 min Apgar 0.002 0.05 -2.714 – 3.444 0.809
Birth Temperature 0.015 -0.122 -1.985 – 1.086 0.551
Gravidity 0.012 -0.122 -19.559 – 11.174 0.579
Maternal Age 0.137 -0.370 -47.048 – 1.302 0.063
Maternal BMI 0.185 0.430 3.069 – 42.498 0.025
Social Class 0.023 0.153 -862.086 – 1893.458 0.448
PSS 0.038 0.194 -25.554 – 72.702 0.332
STAI 0.008 0.088 -21.420 – 33.170 0.661
EPDS 0.045 0.212 -1.231 – 3.962 0.289
Supplementary table 6: Placental FKBP5 expression and continuous variables. Linear 
regression analysis. Maternal BMI positively associated with FKBP5 levels. P < 0.05 *. 
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Supplementary figure 3: Placental gene expression, gender and obstetric outcomes
Supplementary figure 3: Expression of placental HSD11B2, NR3C1 and FKBP5 in relation 
newborn sex and obstetric outcomes. No significant differences between groups. Unpaired 
Student’s t-test. P < 0.005. Spontaneous (Spont), Induction (Induct), Spontaneous rupture of 
membranes (SROM), Artificial Rupture of membranes (AROM), Spontaneous vaginal 
delivery (SVD), Operative delivery (Opera) Vaginal delivery (Vagin) and C-Section delivery 
(C-Sect). 
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Abstract
The experience of maternal distress in pregnancy is often linked with poorer obstetric outcomes 
for women as well as adverse outcomes for offspring. Alterations in placental glucocorticoid 
signalling and subsequent increased fetal exposure to cortisol have been suggested to underlie 
this relationship. In the current study, 121 pregnant women completed the Perceived Stress 
Scale, State Trait Anxiety Inventory and Edinburgh Postnatal Depression Scale in the third 
trimester of pregnancy. Placental samples were collected after delivery. Maternal history of 
psychiatric illness and miscarriage were significant predictors of poorer mental health in 
pregnancy. Higher anxiety was associated with an increase in women delivering via elective 
Caesarean Section, and an increase in bottle-feeding. Birth temperature was mildly reduced 
among infants of women with high levels of depressive symptomology. Babies of mothers who 
scored high in all stress (cumulative distress) measures had reduced 5-minute Apgar scores. 
High cumulative distress reduced the expression of placental HSD11B2 mRNA and increased 
the expression of placental NR3C1 mRNA. These data support a role for prenatal distress as a 
risk factor for altered obstetric outcomes. The alterations in placental gene expression support 
a role for altered placental glucocorticoid signalling in the relationship between maternal 
prenatal distress and adverse outcomes. 
